Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Yijian Pharmaceutical is a comprehensive pharmaceutical enterprise based in China that specializes in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates multiple production lines certified by Chinese GMP standards, producing a wide range of products including tablets, capsules, and granules. Its portfolio primarily focuses on anti-infectives, cardiovascular treatments, and gastrointestinal medications. Shandong Yijian Pharmaceutical serves both domestic and international markets, positioning itself as a key supplier of high-quality generic medications and chemical raw materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Yijian Pharmaceutical.